Laurent Audoly
Fondatore presso Cytovia Therapeutics, Inc.
Provenienza dei contatti di primo grado di Laurent Audoly
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY.
10
| Private Company | Biotechnology | 10 |
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incendia Therapeutics, Inc. develops a novel class of anti-cancer therapies. The company is based in Boston, MA. The company was founded in 2003 by Laurent Audoly, Colin Glenn Begley, Olga Granaturova, Guy Travis Clifton. Laurent Audoly has been the CEO since 2003.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom.
6
| Subsidiary | Biotechnology | 6 |
Cytovia Holdings, Inc.
4
| Private Company | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Laurent Audoly tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
The Walter & Eliza Hall Institute of Medical Research
 The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Corporate Officer/Principal | |
| University of Oxford | College/University | Graduate Degree Doctorate Degree | |
RIEMSER Pharma GmbH
 RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Drexel University | College/University | Doctorate Degree | |
CACI Ltd.
 CACI Ltd. Packaged SoftwareTechnology Services CACI Ltd. provides consumer and market analysis solutions. Its products include acorn, AnaBase, ORECASTER, ChildView, cygnum, dataACE, EMAIL STUDIO, fresco, infoflow, InSite, and InView. The firm also provides integrated marketing, location planning, technology, and network solutions. The company was founded in 1975 and is headquartered in London, the United Kingdom. | Packaged Software | Director of Finance/CFO | |
| CYNOSURE, INC. | Medical Specialties | Director/Board Member | |
Fox-Pitt, Kelton Ltd.
 Fox-Pitt, Kelton Ltd. Investment ManagersFinance Fox-Pitt, Kelton Ltd. engages in providing investment advisory services. It is also underwriter of equity securities and actively serves as a strategic advisor providing advice on mergers & acquisitions, corporate restructurings and equity capital market transactions for banks, insurance companies and other financial services companies around the world. The company was founded in 1971 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Undergraduate Degree | |
| New York University | College/University | Masters Business Admin | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
| Western Australian Institute For Medical Research | Director/Board Member | ||
| OXFORD BIODYNAMICS PLC | Biotechnology | Founder | |
| IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
| DICE THER | Biotechnology | Director/Board Member | |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
The Marketing Practice (UK) Ltd.
 The Marketing Practice (UK) Ltd. Internet Software/ServicesTechnology Services The Marketing Practice (UK) Ltd. provides digital media and marketing services. The company is based in London, UK. and has subsidiaries in United Kingdom, United States and Australia. The British company was founded in 2002. The CEO is Matthew David Harper. | Internet Software/Services | Director of Finance/CFO | |
| Sibelius Ltd. | Director/Board Member | ||
Mortgage Gym Ltd.
 Mortgage Gym Ltd. Packaged SoftwareTechnology Services Mortgage Gym Ltd. develops mortgage mobile application. The company was founded by David John Stephen Vertannes and John Ingram in 2016 and is headquartered in Reading, the United Kingdom. | Packaged Software | Director/Board Member | |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Edgify AI Ltd.
 Edgify AI Ltd. Packaged SoftwareTechnology Services Edgify AI Ltd. provides a distributed and collaborative framework for training deep learning (DL) and machine learning (ML) models at the edge. The company is based in London, UK. The British company allows any organization to train DL and ML models on their own edge devices. The company was founded in 2014 by Ofri Ben-Porat and Nadav Tal-Israel, and Ofri Ben-Porat has been the CEO since 2014. | Packaged Software | Director/Board Member | |
Northpond Ventures LLC
 Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | Investment Managers | Director/Board Member | |
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Vector Therapeutics, Inc.
 Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member | |
| Footsteps Foundation | Director/Board Member | ||
| Sandpiper Lnvestment Ltd. | Director/Board Member | ||
| Sandpiper Resort Ltd. | Director/Board Member | ||
| Monsoon Dune Pvt Ltd. | Director/Board Member | ||
| Monsoon Beach Pvt Ltd. | Director/Board Member | ||
| Kingfisher Villa Pvt Ltd. | Director/Board Member | ||
| Sibbasbridge Services Ltd. | Director/Board Member | ||
| 3DM (Asia) Ltd. | Director/Board Member | ||
| TQP Technology Ltd. | Director/Board Member | ||
| Pure Business Ltd. | Director/Board Member | ||
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Investment Managers | Director/Board Member | |
| KYVERNA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Université Paris-Saclay | College/University | Undergraduate Degree | |
Totus Medicines, Inc.
 Totus Medicines, Inc. Pharmaceuticals: MajorHealth Technology Totus Medicines, Inc. manufactures drug products. The company is based in Cambridge, MA. The company was founded by Neil Dhawan, Jason Pontin. Neil Dhawan has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 24 |
| Regno Unito | 23 |
| Australia | 4 |
| Germania | 2 |
| Francia | 2 |
Settori
| Health Technology | 22 |
| Consumer Services | 9 |
| Technology Services | 5 |
| Finance | 5 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 119 |
| Corporate Officer/Principal | 32 |
| Independent Dir/Board Member | 26 |
| Founder | 23 |
| Chief Executive Officer | 19 |
Contatti più connessi
| Insiders | |
|---|---|
| Michael Friedman | 30 |
| Shaan Gandhi | 22 |
| Daniel Teper | 19 |
| Jason Aryeh | 18 |
| Christian Millar | 16 |
| Thomas H. Robinson | 14 |
| Wendye Robbins | 12 |
| Christopher O’Donnell | 11 |
| Steve Liapis | 11 |
| Colin Glenn Begley | 8 |
| Huw Jones | 8 |
| Kaouthar Lbiati | 8 |
| Stanley Frankel | 7 |
| Nicholas Robbins-Cherry | 4 |
| Olivier Gouédard | 4 |
- Borsa valori
- Insiders
- Laurent Audoly
- Connessioni Società
